166 related articles for article (PubMed ID: 29066912)
21. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
22. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
23. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
Fu J; Su Y; Liu Y; Zhang XY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
[No Abstract] [Full Text] [Related]
24. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
25. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
26. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
27. In-silico identification of frequently mutated genes and their co-enriched metabolic pathways associated with Prostate cancer progression.
Singh AN; Sharma N
Andrologia; 2021 Dec; 53(11):e14236. PubMed ID: 34468989
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
31. Altered methylation of multiple genes in carcinogenesis of the prostate.
Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T
Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.
Li Y; Pan P; Qiao P; Liu R
Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
[TBL] [Abstract][Full Text] [Related]
33. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
[TBL] [Abstract][Full Text] [Related]
34. Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer.
Liu J; Li H; Sun L; Wang Z; Xing C; Yuan Y
Cancer Cell Int; 2017; 17():75. PubMed ID: 28794688
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analyses of DNA methylation and gene expression profiles of Kawasaki disease.
Chang D; Qian C; Li H; Feng H
J Cell Biochem; 2019 Aug; 120(8):13001-13011. PubMed ID: 30861201
[TBL] [Abstract][Full Text] [Related]
36. Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.
Geybels MS; Alumkal JJ; Luedeke M; Rinckleb A; Zhao S; Shui IM; Bibikova M; Klotzle B; van den Brandt PA; Ostrander EA; Fan JB; Feng Z; Maier C; Stanford JL
Clin Epigenetics; 2015; 7():128. PubMed ID: 26692910
[TBL] [Abstract][Full Text] [Related]
37. Aberrant DNA methylation associated with Alzheimer's disease in the superior temporal gyrus.
Gao Z; Fu HJ; Zhao LB; Sun ZY; Yang YF; Zhu HY
Exp Ther Med; 2018 Jan; 15(1):103-108. PubMed ID: 29375678
[TBL] [Abstract][Full Text] [Related]
38. An Epigenome-Wide DNA Methylation Map of Testis in Pigs for Study of Complex Traits.
Wang X; Kadarmideen HN
Front Genet; 2019; 10():405. PubMed ID: 31114612
[TBL] [Abstract][Full Text] [Related]
39. Analysis of methylation profiling data of hyperplasia and primary and metastatic endometrial cancers.
Wu X; Miao J; Jiang J; Liu F
Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():161-166. PubMed ID: 28910750
[TBL] [Abstract][Full Text] [Related]
40. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
